VEGFA and COVID-19: Together, the above results demonstrate that inhibition of the ERK/VEGF axis could rescue the compromised vascular barrier and alleviate the intestinal inflammation induced by spike RBD, highlighting a novel strategy to treat GI symptoms of COVID‐19.